Vadodara-based Allchem Lifesciences on Friday issued an addendum to its draft red herring prospectus (DRHP) with the Securities and Exchange Board of India (Sebi), highlighting a suit filed by Alkem Laboratories against it in the Delhi High Court.
The suit, filed on 23 April, alleges infringement of Alkem Labs’ trademark with respect to the use of the name Allchem by the initial public offering (IPO)-bound company.
In its submission to the Delhi HC, Alkem has sought a permanent injunction on the use of the name “Allchem” and the offer under this name, along with damages of ₹2 crore for the